Skip to content

The EGF Eye Serum Wins Marie Claire Skincare Awards 2022.

Best Eye Product.

EGF Eye Serum Awarded Best Eye Product.

We are thrilled to announce that the BIOEFFECT EGF EYE SERUM has won the BEST EYE PRODUCT award in the 2022 Marie Claire Skincare Awards. Now in its third year, the awards recognise the very best skin products on the market.

After rigorous testing by the Marie Claire Expert judging panel, we are delighted that our hero eye product, the EGF Eye Serum has been awarded this accolade.

Committed to championing brands that are working towards a greener future, Marie Claire’s expert judging panel of over 50 world-renowned dermatologists, facialists, doctors, sustainability champions, beauty influencers and award-winning journalists, come together to recognise the best of the best in skincare and celebrate the brands making the right choices when it comes to sustainability. 

This serum from Icelandic brand BIOEFFECT uses EGF (Epidermal Growth Factor) biotechnology to help the skin boost its production of collagen. This is delivered in a cooling rollerball for depuffing benefits. I love the delivery system — it’s easy to use with the rollerball.”

Ruby Hammer, Judging Panel

Award-Winning Eye Serum Targeting Visible Signs of Aging.

Our BIOEFFECT EGF Eye Serum is a powerful, revitalizing anti-ageing formula, specifically developed to target the delicate eye area. A refreshing and revitalising eye serum for wrinkles, fine lines, and puffiness it restores younger-looking skin with a higher concentration of Barley EGF, a moisture-binding and skin-rejuvenating protein, that helps support the skin’s natural collagen production and is essential for keeping skin looking smooth, healthy, and youthful.

We are proud to add yet another established and highly coveted win to our growing list of awards.

Visit Marie Claire’s webpage for more on the Marie Claire Skincare Awards 2022.

EGF Eye Serum.

Find Out More on Our Award-Winning Eye Product.

EGF Serum.

Also Highly Commended by the Marie Claire Judging Panel.

Loading...